Professional
Added to YB: 2024-08-28
Pitch date: 2024-07-23
RXST [bullish]
RxSight, Inc.
-73.79%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States.
Market Cap
$400.1M
Pitch Price
$48.15
Price Target
N/A
Dividend
N/A
EV/EBITDA
-4.60
P/E
-11.07
EV/Sales
1.30
Sector
Health Care Equipment and Supplies
Category
growth
Show full summary:
Baird Small/Mid Cap Growth Equity New Position: RxSight, Inc.
RXST: Novel adjustable intra-ocular lens for cataract surgery with superior visual outcomes. Early in growth cycle. New position initiated.
Read full article (1 min)